News

UC Riverside-led national survey of MS specialists finds nearly 10% had been redeployed to the front lines of COVID-19 patient care

Even as vaccinations across the U.S. were ramping up due to the popularity and availability of the one-dose Johnson & Johnson vaccine, the CDC called a timeout due to reports of serious blood clots

Study by UC Riverside researchers will examine impacts of remote learning on families with children in grades K-12

PANDORA sequencing method developed by UC Riverside-led team can detect once-undetectable small RNAs

T he vaccine passport is coming. The likelihood of a “passport” being required — or perhaps just requested — for travel, and to return to school and work, seems a certainty. New York state is testing a smartphone app that would verify vaccine status for entry into events. IBM is...

The Regents of the University of California have given final approval for the construction of the School of Medicine’s new Education Building II at UC Riverside. The vote, which approved the final design, the full budget, and the California Environmental Quality Act, or CEQA, findings, took place during the Regents’...

UC Riverside biomedical scientists were part of an international team that identified the coronavirus strain

Immunity generated by vaccination is better than immunity from an actual infection, says an expert

C OVID-19 is far from beaten. Vaccines may not be the ultimate panacea to haul us out of the pandemic crisis. In the future, will outbreaks of SARS-CoV-2, the virus that causes COVID-19, arrive in waves every winter? Might COVID-19 never go away? Experts at the University of California, Riverside...

UC Riverside-led study examined the effects of the medication risperidone on brain metabolism in stuttering

UC Riverside-led mouse study stresses MS treatment should be started early

UC Riverside epidemiologist answers this and other questions in Q&A

Dr. David Lo at the UC Riverside School of Medicine is an expert on vaccines

A UC Riverside-led study, funded by Merck, is set to find out

UC Riverside study examines molecular pathways that may instigate seizures in some multiple sclerosis patients

Phase 2 study investigates efficacy of the drug ecopipam developed by Emalex Biosciences Inc.

Meeting virtually with people outside your household is safest, says UC Riverside epidemiologist

Host campus UC Riverside will be joined by UC Davis and UC Merced

Neural crest study results could boost stem cell therapies

The news arrived Monday that the world has been awaiting since spring: a vaccine has been developed that shows a high degree of efficacy in late-stage trials: 90%. That puts it in the company of effective vaccines such as for measles, and well beyond what the medical community hoped for...